A detailed history of Owen La Rue, LLC transactions in Amgen Inc stock. As of the latest transaction made, Owen La Rue, LLC holds 2,683 shares of AMGN stock, worth $704,689. This represents 0.52% of its overall portfolio holdings.

Number of Shares
2,683
Previous 2,683 -0.0%
Holding current value
$704,689
Previous $838,000 3.1%
% of portfolio
0.52%
Previous 0.57%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$262.75 - $319.31 $4,992 - $6,066
-19 Reduced 0.7%
2,683 $838,000
Q1 2024

May 13, 2024

SELL
$268.87 - $324.56 $26,618 - $32,131
-99 Reduced 3.53%
2,702 $768,000
Q4 2023

Feb 05, 2024

BUY
$255.7 - $288.46 $255 - $288
1 Added 0.04%
2,801 $806,000
Q3 2023

Nov 15, 2023

SELL
$218.65 - $271.46 $43,730 - $54,291
-200 Reduced 6.67%
2,800 $752,000
Q2 2023

Aug 09, 2023

BUY
$214.27 - $253.37 $73,494 - $86,905
343 Added 12.91%
3,000 $666,000
Q4 2022

Feb 13, 2023

BUY
$229.03 - $291.01 $608,532 - $773,213
2,657 New
2,657 $702 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $140B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Owen La Rue, LLC Portfolio

Follow Owen La Rue, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Owen La Rue, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Owen La Rue, LLC with notifications on news.